Medistim ASA (STO:MEDIO)

Market Cap	4.20B +12.0%
Revenue (ttm)	703.44M +17.9%
Net Income	152.51M +27.0%
EPS	8.34 +27.3%
Shares Out	n/a
PE Ratio	27.56
Forward PE	24.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115
Open	231.00
Previous Close	n/a
Day's Range	231.00 - 231.00
52-Week Range	188.00 - 284.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 159
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 24.38% compared to the previous year's 562.60 million. Earnings were 159.21 million, an increase of 53.33%.

Financial numbers in NOK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 13, 2026

Data Sources Report a data error